Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: ER-positive Her2-negative Early Breast Cancer
Interventions: DIAGNOSTIC_TEST: Genomic test
Sponsor: UNICANCER